Aldeyra Therapeutics Schedules Webcast and Conference Call to Announce Results from Phase 2b Dry Eye Disease Clinical Trial
Go back to Aldeyra Therapeutics Schedules Webcast and Conference Call to Announce Results from Phase 2b Dry Eye Disease Clinical Trial| ALDEYRA THERAPEUT (NASDAQ: ALDX) | Delayed: 2.28 +0.01 (0.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.27 | 52 Week High | $8.19 | |||
| Open | $2.25 | 52 Week Low | $3.39 | |||
| Day High | $2.36 | P/E | N/A | |||
| Day Low | $2.21 | EPS | $0.00 | |||
| Volume | 1,199,998 | |||||
